Australia's Therapeutic Goods Administration (TGA) has said it won't approve Eisai and Biogen's Alzheimer's disease therapy ...

In another positive development for the lung cancer community, NICE has also given its blessing to NHS use of MSD's $25 ...

The number of U.S. children who suffer seizures after swallowing prescription medications or illicit drugs has doubled in ...

BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that the Therapeutic Goods Administration (TGA) of ...

Most Americans 50 and older don't place much trust in health advice generated by artificial intelligence, a new survey finds.

A much-anticipated drug that holds the promise of delaying symptoms of Alzheimer’s disease will not be available in Australia ...

On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 250,487 shares ...

We recently published a list of 10 Biggest Stocks with Negative Beta to Consider. In this article, we are going to take a ...

Eisai will request a reconsideration of this decision under Section 60* of the Therapeutic Goods Act within 90 days to make lecanemab available for eligible people living with early AD in Australia.

Airline kitchens are known for their own food safety problems, but rarely do those ground-based issues result in a loss of food service in the air. Delta Air Lines, however, made that connection ...

Plans for a game-changing rail link to Phuket are gathering steam—but officials are staying tight-lipped. Phang Nga Governor Supoj Rotreuang Na Nongkhai has just held a high-level meeting to review ...

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...